BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18296054)

  • 1. Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives.
    Cheng Y; An LK; Wu N; Wang XD; Bu XZ; Huang ZS; Gu LQ
    Bioorg Med Chem; 2008 Apr; 16(8):4617-25. PubMed ID: 18296054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.
    Dallavalle S; Gattinoni S; Mazzini S; Scaglioni L; Merlini L; Tinelli S; Beretta GL; Zunino F
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1484-9. PubMed ID: 18248813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and cytotoxic activity of substituted luotonin A derivatives.
    Dallavalle S; Merlini L; Beretta GL; Tinelli S; Zunino F
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5757-61. PubMed ID: 15501036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure-activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives.
    Loza-Mejía MA; Olvera-Vázquez S; Maldonado-Hernández K; Guadarrama-Salgado T; González-Sánchez I; Rodríguez-Hernández F; Solano JD; Rodríguez-Sotres R; Lira-Rocha A
    Bioorg Med Chem; 2009 May; 17(9):3266-77. PubMed ID: 19364657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.
    Kim JS; Rhee HK; Park HJ; Lee IK; Lee SK; Suh ME; Lee HJ; Ryu CK; Choo HY
    Bioorg Med Chem; 2007 Jan; 15(1):451-7. PubMed ID: 17035025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of cytotoxic 11-aminoalkenylindenoisoquinoline and 11-diaminoalkenylindenoisoquinoline topoisomerase I inhibitors.
    Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M
    Bioorg Med Chem; 2004 Oct; 12(19):5147-60. PubMed ID: 15351398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cytotoxic evaluation, and DNA binding of novel thiazolo[5,4-b]quinoline derivatives.
    Loza-Mejía MA; Maldonado-Hernández K; Rodríguez-Hernández F; Rodríguez-Sotres R; González-Sánchez I; Quintero A; Solano JD; Lira-Rocha A
    Bioorg Med Chem; 2008 Feb; 16(3):1142-9. PubMed ID: 18035542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, topoisomerase I inhibition and structure-activity relationship study of 2,4,6-trisubstituted pyridine derivatives.
    Zhao LX; Moon YS; Basnet A; Kim EK; Jahng Y; Park JG; Jeong TC; Cho WJ; Choi SU; Lee CO; Lee SY; Lee CS; Lee ES
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1333-7. PubMed ID: 14980693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumoral activity of novel thiazolobenzotriazole, thiazoloindolo[3,2-c]quinoline and quinolinoquinoline derivatives.
    Beauchard A; Jaunet A; Murillo L; Baldeyrou B; Lansiaux A; Chérouvrier JR; Domon L; Picot L; Bailly C; Besson T; Thiéry V
    Eur J Med Chem; 2009 Oct; 44(10):3858-65. PubMed ID: 19427714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terbenzimidazoles: influence of 2"-, 4-, and 5-substituents on cytotoxicity and relative potency as topoisomerase I poisons.
    Kim JS; Yu C; Liu A; Liu LF; LaVoie EJ
    J Med Chem; 1997 Aug; 40(18):2818-24. PubMed ID: 9288163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted 2,5'-Bi-1H-benzimidazoles: topoisomerase I inhibition and cytotoxicity.
    Kim JS; Gatto B; Yu C; Liu A; Liu LF; LaVoie EJ
    J Med Chem; 1996 Feb; 39(4):992-8. PubMed ID: 8632422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiproliferative activity of indolizinophthalazine-5,12-dione derivatives, DNA topoisomerase IB inhibitors.
    Shen DQ; Wu ZP; Wu XW; An ZY; Bu XZ; Gu LQ; Huang ZS; An LK
    Eur J Med Chem; 2010 Sep; 45(9):3938-42. PubMed ID: 20638158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel synthetic isoquinolino[5,4-ab]phenazines: inhibition toward topoisomerase I, antitumor and DNA photo-cleaving activities.
    Yang P; Yang Q; Qian X; Cui J
    Bioorg Med Chem; 2005 Nov; 13(21):5909-14. PubMed ID: 16115776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
    Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
    Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity.
    Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY
    Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.
    Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3659-63. PubMed ID: 15203138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 6-substituted 6H-indolo[2,3-b]quinolines as novel cytotoxic agents and topoisomerase II inhibitors.
    Kaczmarek L; Luniewski W; Zagrodzki B; Godlewska J; Osiadacz J; Wietrzyk J; Opolski A; Peczyńska-Czoch W
    Acta Pol Pharm; 2002; 59(3):199-207. PubMed ID: 12230247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.
    Godlewska J; Luniewski W; Zagrodzki B; Kaczmarek L; Bielawska-Pohl A; Dus D; Wietrzyk J; Opolski A; Siwko M; Jaromin A; Jakubiak A; Kozubek A; Peczyñska-Czoch W
    Anticancer Res; 2005; 25(4):2857-68. PubMed ID: 16080538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship.
    Abdel-Aziz M; Matsuda K; Otsuka M; Uyeda M; Okawara T; Suzuki K
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1669-72. PubMed ID: 15026047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, mode of action, and biological activities of rebeccamycin bromo derivatives.
    Moreau P; Anizon F; Sancelme M; Prudhomme M; Sevère D; Riou JF; Goossens JF; Hénichart JP; Bailly C; Labourier E; Tazzi J; Fabbro D; Meyer T; Aubertin AM
    J Med Chem; 1999 May; 42(10):1816-22. PubMed ID: 10346933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.